Articles
Optimizing Multiplex qPCR: TaqMan QSY and QSY2 Probes vs. IDT Probes
The new Applied Biosystems™ TaqMan™ QSY™2 probes enhance multiplexing capabilities, allowing users to detect up to six targets in a single real-time PCR (qPCR) reaction with increased sensitivity, dynamic range, and performance consistency
Revolutionize Drug Development with AI/ML
Poor solubility remains one of the most significant challenges in drug development, affecting over 70% of molecules and hindering their path to clinical trials.
Accelerate Drug Development with In Silico Modeling
The path to successful drug development is filled with challenges, from managing complex molecules to ensuring bioavailability and regulatory compliance.
Recombinant Antibody Technology
Recombinant antibody technology addressed many problems associated with hybridoma-based platforms for biologics production, opening the door to new classes of drugs.
Advancing Drug Discovery: Integrating 3D Spheroid Models and Live-Cell Analysis for Compound Screening
Phenotypic screening, which measures defined changes in cellular phenotype in response to a multitude of compounds, is essential in early-stage drug discovery.
Early-stage biotech: The wrong outsourcing strategy costs more than time
For early-stage biotech companies, innovation is just the beginning—the greater challenge lies in navigating the complex development path with limited time, resources, and visibility.
From Discovery to Delivery: The Rise of New Modalities
In the rapidly evolving landscape of pharmaceuticals and biotechnology, the emergence of multimodal drug discovery heralds a transformative era, where innovation and strategic foresight are paramount.
The New RNA World: Evolving RNA from Messenger to Versatile Therapeutic
RNA has evolved from a molecular messenger into a powerful and versatile therapeutic tool.
Ensuring compliance through collaboration: managing raw material changes in cell and gene therapy regulatory filings
Cell and gene therapy manufacturing depends on specialized raw materials, ranging from upstream reagents to downstream excipients, that are essential to product quality, consistency, and safety.
The Evolution of Antibody Drug Discovery: Unlocking Innovation with Bioinformatic and AIs
Since monoclonal antibodies (mAbs) were developed and received their first approval, they became indispensable as research tools and biotherapeutic agents.
